Eijiro Omoto

2.0k total citations · 1 hit paper
45 papers, 1.3k citations indexed

About

Eijiro Omoto is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Eijiro Omoto has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 11 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Eijiro Omoto's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (10 papers) and Retinoids in leukemia and cellular processes (4 papers). Eijiro Omoto is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (10 papers) and Retinoids in leukemia and cellular processes (4 papers). Eijiro Omoto collaborates with scholars based in Japan, United States and Greece. Eijiro Omoto's co-authors include Ryuzo Ohno, Kenji Saito, Norio Asou, Shuichi Miyawaki, Ryuzo Ueda, Kazutaka Kuriyama, Saburo Minami, Chihiro Shimazaki, Hakumei Oh and Shohei Yokota and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Archives of Biochemistry and Biophysics.

In The Last Decade

Eijiro Omoto

44 papers receiving 1.2k citations

Hit Papers

Prognostic implication of FLT3 and N-RAS gene mutations i... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eijiro Omoto Japan 14 900 535 311 190 189 45 1.3k
Philippe Rousselot France 20 870 1.0× 799 1.5× 243 0.8× 279 1.5× 269 1.4× 44 1.5k
Yataro Yoshida Japan 18 664 0.7× 404 0.8× 194 0.6× 177 0.9× 114 0.6× 85 1.1k
Inger Marie S. Dahl Norway 20 1.1k 1.2× 696 1.3× 398 1.3× 427 2.2× 98 0.5× 37 1.7k
S. Faderl United States 16 882 1.0× 417 0.8× 393 1.3× 240 1.3× 214 1.1× 24 1.2k
Devendra Hiwase Australia 20 944 1.0× 378 0.7× 489 1.6× 296 1.6× 103 0.5× 107 1.3k
Tomas Ahlgren Sweden 17 967 1.1× 353 0.7× 436 1.4× 152 0.8× 253 1.3× 31 1.3k
Amanda F. Cashen United States 16 1.1k 1.2× 642 1.2× 227 0.7× 450 2.4× 233 1.2× 72 1.6k
Michal Bar‐Natan United States 15 719 0.8× 524 1.0× 364 1.2× 312 1.6× 98 0.5× 41 1.3k
Sylvain Thépot France 19 1.0k 1.2× 542 1.0× 408 1.3× 200 1.1× 214 1.1× 81 1.3k
Fumiharu Yagasaki Japan 20 1.2k 1.3× 526 1.0× 333 1.1× 217 1.1× 607 3.2× 61 1.5k

Countries citing papers authored by Eijiro Omoto

Since Specialization
Citations

This map shows the geographic impact of Eijiro Omoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eijiro Omoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eijiro Omoto more than expected).

Fields of papers citing papers by Eijiro Omoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eijiro Omoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eijiro Omoto. The network helps show where Eijiro Omoto may publish in the future.

Co-authorship network of co-authors of Eijiro Omoto

This figure shows the co-authorship network connecting the top 25 collaborators of Eijiro Omoto. A scholar is included among the top collaborators of Eijiro Omoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eijiro Omoto. Eijiro Omoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omoto, Eijiro, Hiroaki Kumagai, Yuta Katayama, et al.. (2022). The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donors. International Journal of Hematology. 115(6). 882–889. 1 indexed citations
2.
Sugita, Junichi, Shuichi Ota, Tomohiko Kamimura, et al.. (2019). The Impact of Reduced Dose of Posttransplant Cyclophosphamide in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(3). S57–S58. 1 indexed citations
3.
Omoto, Eijiro & Masahiro Harada. (2015). Transfusion-Associated Acute Lung Injury. PubMed. 55(9). 2305–9.
4.
Igarashi, Aiko, Morito Kurata, Ken‐Ichi Imadome, et al.. (2012). [Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma].. PubMed. 53(1). 87–91. 2 indexed citations
5.
Omoto, Eijiro, et al.. (2001). Very late antigen-5 and leukocyte function-associated antigen-1 are critical for early stage hematopoietic progenitor cell homing. Annals of Hematology. 80(7). 387–392. 20 indexed citations
6.
Nawa, Yukifumi, Takanori Teshima, Kazutaka Sunami, et al.. (2000). G-CSF reduces IFN-γ and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplantation. 25(10). 1035–1040. 47 indexed citations
7.
Miyawaki, Shuichi, T Kobayashi, S Minami, et al.. (2000). [Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group].. PubMed. 27(8). 1160–7. 2 indexed citations
8.
Katayama, Yoshio, Katsuji Shinagawa, Takanori Teshima, et al.. (1998). Bone marrow necrosis in a patient with acute myeloblastic leukemia during administration of G-CSF and rapid hematologic recovery after allotransplantation of peripheral blood stem cells. American Journal of Hematology. 57(3). 238–240. 18 indexed citations
9.
Kojima, Kensuke, Eijiro Omoto, Masamichi Hara, et al.. (1998). Myelodysplastic syndrome with translocation (8; 21): a distinct myelodysplastic syndrome entity or M2-acute myeloid leukemia with extensive myeloid maturation?. Annals of Hematology. 76(6). 279–282. 15 indexed citations
10.
Katayama, Yoshio, Tomonori Yano, Akihiro Bessho, et al.. (1997). The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplantation. 19(3). 283–287. 73 indexed citations
11.
Katayama, Yoshio, Tadashi Yoshino, Yoshinobu Matsuo, et al.. (1997). Common clonal origin of lymphocytes and plasma cells in splenic lymphoma with villous lymphocytes. British Journal of Haematology. 97(3). 626–634. 3 indexed citations
12.
Takeuchi, Makoto, Tomofumi Yano, Eijiro Omoto, et al.. (1997). Re‐induction of complete remission with a new synthetic retinoid, Am‐80, for relapse of acute promyelocytic leukaemia previously treated with all‐trans retinoic acid. British Journal of Haematology. 97(1). 137–140. 6 indexed citations
14.
Nawa, Yuichiro, Takanori Teshima, Kazutaka Sunami, et al.. (1997). Responses of Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cells to Alloantigen Stimulation. Blood. 90(4). 1716–1718. 3 indexed citations
16.
Omoto, Eijiro, et al.. (1991). Characterization of FDCP-2, a cloned hemopoietic progenitor cell deficient in homing protein.. PubMed. 19(9). 978–84. 2 indexed citations
17.
Omoto, Eijiro, José J. Minguell, & Mehdi Tavassoli. (1990). Proteoglycan synthesis by cultured liver endothelium: The role of membrane-associated heparan sulfate in transferrin binding. Experimental Cell Research. 187(1). 85–89. 10 indexed citations
18.
Omoto, Eijiro, et al.. (1990). Measurement of Homing Receptors on the Surface of Leukemic and Nonleukemic Cell Lines. Pathobiology. 58(3). 179–184. 5 indexed citations
19.
Omoto, Eijiro & Mehdi Tavassoli. (1989). Purification and characterization of ceruloplasmin receptors.. PubMed. 102. 170–5. 2 indexed citations
20.
Omoto, Eijiro & Mehdi Tavassoli. (1989). The role of endosomal traffic in the transendothelial transport of ceruloplasmin in the liver. Biochemical and Biophysical Research Communications. 162(3). 1346–1350. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026